AKT1 and undifferentiated pleomorphic sarcoma: Our in vitro study yielded evidence that 17-DMAG decreased the viability and the invasiveness of UPS cells, and 17-DMAG inactivated the kinase activity of the Akt/mTOR and MAPK pathways although the cell motility remained unchanged.